Some cancers, like prostate cancer, secrete EVs with CUB-domain containing protein 1 (CDCP1), a transmembrane protein inducer of osteoclastogenesis that has been shown to have an amplified effect in the presence of RANKL [160]. Here, CDCP1 is linked to prostate cancer.